News

SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company's MantraM Mobile Robotic Telesurgery Unit

  • FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first robotic telesurgery performed from the Company's MantraM mobile robotic telesurgery unit (the “MantraM bus”).
    09/09/2025

Ss Innovations (SSII) Q2 Revenue Up 122%

  • Ss Innovations (SSII) Q2 Revenue Up 122%
    08/07/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

SS Innovations International, Inc. (SSII) can sell. Click on Rating Page for detail.

The price of SS Innovations International, Inc. (SSII) is 6.0729 and it was updated on 2025-09-12 11:00:26.

Currently SS Innovations International, Inc. (SSII) is in undervalued.

News
    
News

SS Innovations Reports Second Quarter 2025 Financial Results

  • Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth    Fort Lauderdale, FL. August 7, 2025 – PRISM MediaWire – SS Innovations International, Inc.
    Thu, Aug. 07, 2025

SS Innovations Reports Second Quarter 2025 Financial Results

  • Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth    FORT LAUDERDALE, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2025.
    Thu, Aug. 07, 2025

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

  • Performed by Dr. Sudhir Srivastava utilizing the Company's SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL, July 22, 2025 – PRISM MediaWire – SS Innovations International, Inc.
    Tue, Jul. 22, 2025

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

  • Performed by Dr. Sudhir Srivastava utilizing the Company's SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France, at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India FORT LAUDERDALE, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's Chairman of the Board and Chief Executive Officer, Dr. Sudhir Srivastava, M.D.
    Tue, Jul. 22, 2025

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

  • Continuing strong procedure growth, including an upsurge in telesurgeries   Fort Lauderdale, FL, July 15, 2025 – PRISM MediaWire – SS Innovations International, Inc.
    Tue, Jul. 15, 2025
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

  • FORT LAUDERDALE, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries.
  • 07/15/2025

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

  • Fort Lauderdale, FL, July 10, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 07/10/2025

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

  • Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric & Robotic Surgery Centre in Indore, India. Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system.
  • 07/10/2025

SS Innovations: A Speculative Bet On Robotic Surgeries

  • SSII is rapidly growing its surgical robotics business, with strong revenue and KPI growth while expanding into new international markets. Despite operating losses and dilution risk, I see a path to profitability as installations and instrument sales accelerate. The stock is aggressively valued, but industry-leading growth and sector hype justify a speculative buy for risk-tolerant investors.
  • 06/19/2025

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

  • Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador PR Audio: Fort Lauderdale, FL, June 16, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 06/16/2025

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

  • SS Innovations Announces Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
  • 06/16/2025

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

  • FORT LAUDERDALE, Fla., May 27, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 05/27/2025

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

  • FORT LAUDERDALE, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's SSi Mantra surgical robotic system has been utilized to successfully perform more than 4,000 robotic surgeries across more than one hundred types of surgeries without any complications, injuries or mortalities.
  • 05/27/2025

SS Innovations Reports First Quarter 2025 Financial Results

  • Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3  Fort Lauderdale, FL, May 14, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 05/14/2025

SS Innovations Reports First Quarter 2025 Financial Results

  • Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3   FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended March 31, 2025.
  • 05/14/2025

SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications

  • All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy FORT LAUDERDALE, Fla., May 08, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 05/08/2025

SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications

  • FORT LAUDERDALE, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company is planning to submit a De Novo Classification Request to the U.S. Food and Drug Administration (the “FDA”) for the SSi Mantra 3 surgical robotic system (the “SSi Mantra 3”) in July 2025.
  • 05/08/2025

SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

  • Press Audio Overview: FORT LAUDERDALE, Fla., May 05, 2025 – PRISM MediaWire –  SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025.
  • 05/05/2025

SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

  • FORT LAUDERDALE, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025.
  • 05/05/2025

SS Innovations Announces Chief Financial Officer Transition

  • FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition.
  • 05/02/2025

SS Innovations Announces Chief Financial Officer Transition

  • Listened: Thomas Wolff · SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL, May 2, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 05/02/2025

SS Innovations to Uplist to Nasdaq

  • FORT LAUDERDALE, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”).
  • 04/24/2025

SS Innovations Achieves Significant Milestones in 2024

  • FORT LAUDERDALE, FL, March 31, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 03/31/2025

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

  • Fort Lauderdale, Fla. March 28, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 03/28/2025

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

  • FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.
  • 03/28/2025

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

  • The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India's first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures.
  • 03/27/2025

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

  • Fort Lauderdale, FL, March 27, 2025 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative robotic surgical technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it successfully performed India's first North-to-South robotic cardiac telesurgery.
  • 03/27/2025

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

  • FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery at the Company's Second Global Multi-Specialty Robotic Surgery Conference (SMRSC), which was held in Gurugram, Delhi National Capital Region (NCR), India, from March 7 - 9, 2025.
  • 03/13/2025

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

  • Fort Lauderdale, FL, March 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 03/13/2025

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

  • Fort Lauderdale, Fla., March 7, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 03/07/2025

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

  • FORT LAUDERDALE, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the launch of its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025), organized in collaboration with leading medical societies from both national and international platforms, to be held in Gurugram, Delhi National Capital Region (NCR), India, from March 7th to 9th , 2025.
  • 03/07/2025

SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3

  • Fort Lauderdale, Fla., January 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.
  • 01/13/2025

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

  • FORT LAUDERDALE, Fla., Dec. 11, 2024 – PRISM MediaWire – SS Innovations International, Inc.
  • 12/11/2024

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

  • FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its new independent registered public accounting firm, BDO India LLP (“BDO”), has completed the re-audit of the Company's consolidated financial statements for the years ended December 31, 2023 and December 31, 2022, which were included in the Company's previously filed Annual Report on Form 10-K for the year ended December 31, 2023 (the “Original Filing”).
  • 12/11/2024

India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

  • FORT LAUDERDALE, Fla., Dec. 10, 2024 – PRISM MediaWire – SS Innovations International, Inc.
  • 12/10/2024

India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

  • SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics SS Innovations reinforces India's position as a hub for technological innovation in healthcare using the SSi Mantra - Made in India, for the World The SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and control for improved patient outcome FORT LAUDERDALE, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has achieved a milestone in Indian medical science by becoming the first and only company in India to receive Central Drugs Standard Control Organization (CDSCO) regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, signifying a significant achievement in surgical robotics.
  • 12/10/2024

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

  • Fort Lauderdale, Fla., November 26, 2024 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population,  has successfully performed the first-ever robotic cardiac surgery in Indonesia.
  • 11/26/2024

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

  • • SS Innovations marks a milestone with the successful completion of Indonesia's first robotic cardiac surgery using its SSi Mantra Surgical Robotic System.•  Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia, a significant achievement in the field of robotic cardiac surgery.
  • 11/26/2024

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

  • Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024 – PRISM MediaWire – SS Innovations International, Inc.
  • 09/30/2024

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

  • FORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Mr.
  • 09/30/2024

Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

  • Fort Lauderdale, FL., September 23, 2024 – PRISM MediaWire – SS Innovations International, Inc.
  • 09/23/2024

Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

  • FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra Surgical Robotic System (the “SSi Mantra”).
  • 09/23/2024

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

  • Fort Lauderdale, FL., September 11, 2024 –  PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update on its progress and timeline in obtaining U.S.
  • 09/11/2024

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

  • FORT LAUDERDALE, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update on its progress and timeline in obtaining U.S. Food and Drug Administration (“FDA”) approvals to market the SSi Mantra Surgical Robotic System (“SSi Mantra”) in the United States.
  • 09/11/2024

SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board

  • Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman FORT LAUDERDALE, FL, September 10, 2024 –  PRISM MediaWire – SS Innovations International, Inc.
  • 09/10/2024

SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board

  • FORT LAUDERDALE, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Dr. Fredric Moll to its Board of Directors, where he will serve as Vice Chairman.
  • 09/10/2024

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

  • Fort Lauderdale, FL., September 3, 2024 – SS Innovations International, Inc.
  • 09/03/2024

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

  • SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador FORT LAUDERDALE, Fla.
  • 09/03/2024

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

  • Fort Lauderdale, FL., August 30, 2024 – PRISM MediaWire – SS Innovations International, Inc.
  • 08/30/2024

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

  • FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update to its shareholders and the investment community on the status of its audit process and the trading market for its common stock.
  • 08/30/2024

Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

  • New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration Fort Lauderdale, FL., July 18, 2024 – SS Innovations International, Inc.
  • 07/18/2024

Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

  • FORT LAUDERDALE, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra-3 Surgical Robotic System (“SSi Mantra) will be unveiled in New York City next week in an exclusive demonstration for media, analysts and the investment community.
  • 07/18/2024

Uh-Oh. 3 Stocks That Are Sorry They Used ‘Sham Audit Mill' BF Borgers

  • In May, the Securities and Exchange Commission (SEC) charged Colorado-based audit firm BF Borgers with massive fraud. Specifically, the SEC stated that the auditor had engaged in “deliberate and systemic failures to comply with Public Company Accounting Oversight Board (PCAOB) standards in its audits and reviews incorporated in more than 1,500 SEC filings from January 2021 through June 2023.
  • 07/14/2024

SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector

  • Fort Lauderdale, FL., July 9, 2024 – SS Innovations International, Inc.
  • 07/09/2024

SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024

  • Annual awards celebrate the best of the surgical robotics industry Fort Lauderdale, FL., June 17, 2024 – SS Innovations International, Inc.
  • 06/17/2024

SS Innovations' SSi Mantra Surgical Robotic System Approved for Use in Indonesia

  • Fort Lauderdale, FL., June 11, 2024 – SS Innovations International, Inc.
  • 06/11/2024

SS Innovations Engages BDO as its new Auditor

  • SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company's commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 – SS Innovations International, Inc.
  • 05/31/2024

SS Innovations Engages BDO as its new Auditor

  • FORT LAUDERDALE, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that it has engaged BDO India LLP (“BDO”) as its independent registered public accounting firm.
  • 05/31/2024

SS Innovations' SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion

  • FORT LAUDERDALE, FL, May 21, 2024 – SS Innovations International, Inc.
  • 05/21/2024

SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System

  • Company's flagship SSi Mantra surgical device has now been used in more than 1000 procedures FORT LAUDERDALE, FL, April 29, 2024 – SS Innovations International, Inc.
  • 04/29/2024

SS Innovations International Announces Q1 2024 Company Updates

  • Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced its Q1 2024 Company updates.
  • 04/22/2024

SS Innovations International Announces Q1 2024 Company Updates

  • Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, FL, April 22, 2024 – SS Innovations International, Inc.
  • 04/22/2024

SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

  • First-ever telesurgery using SSi Mantra performed on an animal in India FORT LAUDERDALE, FL, April 10, 2024 – SS Innovations International, Inc.
  • 04/10/2024

SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

  • FORT LAUDERDALE, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has successfully completed its first-ever telesurgery procedures on an animal in India.
  • 04/10/2024

SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

  • The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India FORT LAUDERDALE, FL, March 12, 2024 – SS Innovations International, Inc.
  • 03/12/2024

SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

  • FORT LAUDERDALE, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world's first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System.
  • 03/12/2024

U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week

  • U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week
  • 02/17/2024

SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company's First Multi-Specialty Robotic Surgical Conference

  • Remote coronary artery suturing performed on animal model via SS Innovations' telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery FORT LAUDERDALE, FL, February 01, 2024 – SS Innovations International, Inc.
  • 02/01/2024

SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company's First Multi-Specialty Robotic Surgical Conference

  • Remote coronary artery suturing performed on animal model via SS Innovations' telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery FORT LAUDERDALE, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, conducted a groundbreaking live telesurgery demonstration at the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC) that was held in Gurugram, Haryana, India on January 19 and 20, 2024.
  • 02/01/2024

SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration

  • FORT LAUDERDALE, FL, January 26, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it has filed a pre-submission application with the U.S.
  • 01/26/2024

SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration

  • FORT LAUDERDALE, Fla., Jan. 26, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it has filed a pre-submission application with the U.S. Food and Drug Administration (FDA) requesting feedback on its SSi Mantra™ Surgical Robotic System.
  • 01/26/2024

SS Innovations Partners with India's Leading Medical Equipment Supplier, Medikabazaar

  • Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India FORT LAUDERDALE, FL, January 25, 2024 – SS Innovations International, Inc.
  • 01/25/2024

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

  • SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System Distinguished guests included the Honorable Governor of Haryana, Mr.
  • 01/22/2024

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

  • SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System Distinguished guests included the Honorable Governor of Haryana, Mr. Bandaru Dattatreya FORT LAUDERDALE, Fla.
  • 01/22/2024

SS Innovations Achieves Significant Milestones in 2023

  • Company's award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures Company Builds Strong Foundation for Future Growth FORT LAUDERDALE, FL, January 8, 2024 – SS Innovations International, Inc.
  • 01/08/2024

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

  • Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries FORT LAUDERDALE, FL, December 26, 2023 – SS Innovations International, Inc.
  • 12/26/2023

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

  • Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries FORT LAUDERDALE, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Fort Lauderdale, FL.
  • 12/26/2023

SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone

  • Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K.
  • 11/27/2023

SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone

  • Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi Mantra Surgical Robotic System Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi Mantra Surgical Robotic System
  • 11/27/2023

SS Innovations International, Inc. to Present at the Emerging Growth Conference on Wednesday July 12, 2023

  • SS Innovations Invites Individual and Institutional Investors as Well as Advisors and Analysts, to Attend Its Real-time, Interactive Presentation at the Emerging Growth Conference
  • 07/10/2023
Unlock
SSII Ratings Summary
SSII Quant Ranking